Esophageal cancer: challenges, concerns, and recommendations for management amidst the COVID-19 pandemic

Authors Tania Triantafyllou, Michael T. Olson, Dimitrios Theodorou, Georgios Zografos, Saurabh Singhal.


Since December 2019, the outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, raising great concern, particularly in immunosuppressed cancer patients. The pandemic situation remains extremely dynamic, which necessitates proactive management decisions from oncologists and oncologic surgeons in effort to mitigate the risk of both SARS-CoV-2 infection and cancer metastasis. Esophageal cancer, in particular, is one of the deadliest types of malignancy worldwide, reflecting both aggressive biology and a lack of adequate treatment. Several challenges and concerns regarding the management of esophageal cancer have been raised in light of the ongoing viral pandemic. The primary aim of this review is to summarize the salient evidence for recommendations and optimal treatment strategies for patients with esophageal cancer amidst the COVID-19 pandemic.

Keywords COVID-19, coronavirus, SARS-CoV-2, esophageal cancer, esophagectomy

Ann Gastroenterol 2020; 33 (5): 453-458

Review Articles